Search

Ping Zhou Phones & Addresses

  • San Leandro, CA
  • Alameda, CA
  • 6555 Shepherd Canyon Rd, Oakland, CA 94611 (510) 336-1377
  • 5638 Thornhill Dr, Oakland, CA 94611 (510) 339-3268 (510) 339-6428
  • 7400 Sepulveda Blvd, Van Nuys, CA 91405
  • Los Angeles, CA

Professional Records

Medicine Doctors

Ping Zhou Photo 1

Ping Zhou

View page
Specialties:
Pediatric Endocrinology
Work:
Childrens Hospital At Montefiore Medical Center Specialty Clinic
3415 Bainbridge Ave FL 4, Bronx, NY 10467
(718) 741-2450 (phone), (718) 405-5609 (fax)
Education:
Medical School
Hunan Med Univ, Changsha City, Hunan, China
Graduated: 1988
Procedures:
Electrocardiogram (EKG or ECG)
Vaccine Administration
Conditions:
Atopic Dermatitis
Bronchial Asthma
Diabetes Mellitus (DM)
Hypoparathyroidism
Peripheral Nerve Disorders
Languages:
English
Spanish
Description:
Dr. Zhou graduated from the Hunan Med Univ, Changsha City, Hunan, China in 1988. She works in Bronx, NY and specializes in Pediatric Endocrinology. Dr. Zhou is affiliated with Montefiore Medical Center.
Ping Zhou Photo 2

Ping Zhou

View page
Specialties:
Radiation Oncology
Work:
Radiation Oncology AssocsRadiation Center Of Greater Nashua
11 N Southwood Dr, Nashua, NH 03063
(603) 880-1590 (phone), (603) 880-1598 (fax)

Elliot Radiation Oncology At Regional Cancer Center Londonderry
40 Buttrick Rd, Londonderry, NH 03053
(603) 552-1600 (phone)
Education:
Medical School
Harvard Medical School
Graduated: 2001
Languages:
English
Description:
Dr. Zhou graduated from the Harvard Medical School in 2001. She works in Nashua, NH and 1 other location and specializes in Radiation Oncology. Dr. Zhou is affiliated with Elliot Hospital and Wentworth-Douglass Hospital.

License Records

Ping Zhou

License #:
29863 - Active
Issued Date:
Jan 27, 2012
Renew Date:
Dec 1, 2015
Expiration Date:
Nov 30, 2017
Type:
Certified Public Accountant

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ping Zhou
President
Sunlift International Inc
2434 W Main St, Alhambra, CA 91801
Ping Zhou
President
General Optoelectronic Devices, Inc
Ret Misc Merchandise
3861 Eagle Flight Dr, Simi Valley, CA 93065
Ping Zhou
Golden Bridge Properties LLC
1669-2 Hollenbeck Ave, Sunnyvale, CA 94087
Ping Zhou
President
Ping Global Inc
366 Sierra Vis Ave, Mountain View, CA 94043
114 Horn Ct, Folsom, CA 95630
Ping Zhou
PH.D. Capital, LLC
Real Estate Investment and Capital Manag · Investor
7595 Newcastle Dr, Cupertino, CA 95014

Publications

Us Patents

Nucleic Acids And Polypeptides

View page
US Patent:
6436703, Aug 20, 2002
Filed:
Sep 22, 2000
Appl. No.:
09/668680
Inventors:
Y. Tom Tang - San Jose CA
Chenghua Liu - San Jose CA
Ping Zhou - San Jose CA
Vinod Asundi - Foster City CA
Jie Zhang - Campbell CA
Aidong J. Xue - Sunnyvale CA
Chongjun Xu - San Jose CA
Radoje T. Drmanac - Palo Alto CA
Assignee:
Hyseq, Inc. - Sunnyvale CA
International Classification:
C12N 1512
US Classification:
435325, 536 231, 536 235, 4353201
Abstract:
The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.

Nucleic Acids And Polypeptides

View page
US Patent:
6569662, May 27, 2003
Filed:
Jul 19, 2000
Appl. No.:
09/620312
Inventors:
Y. Tom Tang - San Jose CA
Ping Zhou - San Jose CA
Radoje T. Drmanac - Palo Alto CA
Assignee:
Hyseq, Inc. - Sunnyvale CA
International Classification:
C12N 900
US Classification:
435212, 435183, 435195, 435213, 435214, 435218, 435219, 435226, 435227
Abstract:
The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.

Pyrrolylalkylidene-Hydrazinecarboximidamide Derivatives As 5-Hydroxytryptamine-6 Ligands

View page
US Patent:
6727270, Apr 27, 2004
Filed:
Feb 13, 2003
Appl. No.:
10/366011
Inventors:
Michael Gerard Kelly - Thousand Oaks CA
Ping Zhou - Plainsboro NJ
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 3140
US Classification:
514370, 514415, 514422, 514424, 548164, 548491, 548505, 548527, 548542
Abstract:
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.

Nucleic Acids And Polypeptides

View page
US Patent:
6743619, Jun 1, 2004
Filed:
Jan 30, 2001
Appl. No.:
09/774528
Inventors:
Y. Tom Tang - San Jose CA
Ping Zhou - Cupertino CA
Ryle Goodrich - San Jose CA
Chenghua Liu - San Jose CA
Vinod Asundi - Foster City CA
Feiyan Ren - Cupertino CA
Jie Zhang - Campbell CA
Qing A. Zhao - San Jose CA
Yonghong Yang - San Jose CA
Aidong J. Xue - Sunnyvale CA
Tom Wehrman - Stanford CA
Dunrui Wang - Poway CA
Radoje T. Drmanac - Palo Alto CA
Assignee:
Nuvelo - Sunnyvale CA
International Classification:
C12N 990
US Classification:
435233, 435234, 536 232
Abstract:
The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.

Methods And Materials Relating To Alpha-2-Macroglobulin-Like Polypeptides And Polynucleotides

View page
US Patent:
6806254, Oct 19, 2004
Filed:
Jan 8, 2001
Appl. No.:
09/756247
Inventors:
Shubhada D. Godbole - Santa Clara CA
Bryan J. Boyle - San Francisco CA
Nancy K. Mize - Mountain View CA
Cenhua Deng - Cupertino CA
Ryle W. Goodrich - San Jose CA
Matthew C. Arterburn - Los Gatos CA
Ping Zhou - Cupertino CA
Y. Tom Tang - San Jose CA
Chenghua Liu - San Jose CA
George Yeung - Mountain View CA
Radoje T. Drmanac - Palo Alto CA
Assignee:
Nuvelo, Inc. - Sunnyvale CA
International Classification:
A61K 3800
US Classification:
514 12, 530350
Abstract:
The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to novel human secreted alpha-2-macroglobulin-like polypeptides. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from fetal brain mRNA (Clontech) (SEQ ID NO: 1) and uterus mRNA (Clontech) (SEQ ID NO: 26). Other aspects of the invention include vectors containing processes for producing novel human secreted alpha-2-macroglobulin-like polypeptides, and antibodies specific for such polypeptides.

Method And Apparatus For Optical Communication

View page
US Patent:
6819819, Nov 16, 2004
Filed:
Jan 7, 2003
Appl. No.:
10/338542
Inventors:
Ping Zhou - Westlake Village CA, 91361
International Classification:
G02B 626
US Classification:
385 16, 398115
Abstract:
A method and apparatus for communications according to various aspects of the present invention comprises a switching system configured to receive optical signals and direct the optical signals along a selected optical path. The switching system suitably includes more than one switch, and at least one of the switches may include a variable refractive material having a first state and a second state, wherein the optical signal is transmitted via a first path when the variable refractive material is in the first state and the individual channel signal is transmitted via a second path when the variable refractive material is in the second state. The switching system may alternatively or additionally include a switch element having a reflective state and a transmissive state, wherein the optical signal is reflected via a first path when the switch element is in the reflective state and the individual channel signal is transmitted via a second path when the switch element is in the transmissive state.

Mono- And Diacylglycerol Acyltransferases And Methods Of Use Thereof

View page
US Patent:
7045326, May 16, 2006
Filed:
Jan 14, 2002
Appl. No.:
10/046924
Inventors:
Sylvaine Cases - Belmont CA, US
Scot J. Stone - Fairfield CA, US
Ping Zhou - Walnut Creek CA, US
Chi-Liang Eric Yen - San Francisco CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12N 9/10
C07H 21/04
US Classification:
435193, 435183, 4353201, 4352523, 435410, 530350, 536 231, 536 232, 536 235
Abstract:
Nucleic acid compositions encoding polypeptide products with diglyceride acyltransferase and/or monoacylglycerol acyltransferase activity, as well as the polypeptide products encoded thereby, i. e. , mammalian DGAT2α and MGAT1 polypeptide products, and methods for producing the same, are provided. Also provided are: methods and compositions for modulating DGAT2α and MGAT1 activity; DGAT2α and MGAT1 transgenic cells, animals and plants, as well as methods for their preparation; and methods for making diglyceride, diglyceride compositions, triglycerides and triglyceride compositions, as well as the compositions produced by these methods. The subject methods and compositions find use in a variety of different applications, including research, medicine, agriculture and industry applications.

Diacylglycerol O-Acyltransferase 2Α (Dgat2Α)

View page
US Patent:
7862819, Jan 4, 2011
Filed:
May 27, 2003
Appl. No.:
10/446441
Inventors:
Sylvaine Cases - Belmont CA, US
Robert V. Farese - San Francisco CA, US
Scot J. Stone - Fairfield CA, US
Ping Zhou - Walnut Creek CA, US
Assignee:
The J. David Gladstone Institutes - Irvine CA
International Classification:
A61K 39/395
C12N 9/10
C12N 15/09
US Classification:
4241461, 435 71, 435193, 435 692, 5303871, 5303881, 5303879, 4241301, 4241411
Abstract:
Nucleic acid compositions encoding mammalian DGAT2α polypeptide products with diglyceride acyltransferase activity, as well as the mammalian DGAT2α polypeptide products encoded thereby and methods for producing the same, are provided. The subject DGAT2α polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications, as well as in treatment therapies and in the production of triacylglycerols.
Ping Z Zhou from San Leandro, CA, age ~64 Get Report